Trial Profile
A Phase II Study of Letrozole in Combination With Bevacizumab in Patients With Estrogen Receptor- and/or Progesterone Receptor-Positive Unresectable Locally Advanced and/or Metastatic (Stage IV) Breast Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Letrozole
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 30 Aug 2017 Status changed from active, no longer recruiting to completed.
- 30 Aug 2017 Status changed from active, no longer recruiting to completed.
- 14 Sep 2012 Planned number of patients changed from 42 to 43 as reported by ClinicalTrials.gov.